Cytonus Therapeutics, Inc. is a San Diego-based biotherapeutic and biotechnology company headquartered in Carlsbad, California. The company develops transformative medicines utilizing a vast platform of proprietary targeted drug delivery systems based on next-generation artificial intelligence and life sciences research.
Subscribe to see Cytonus Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cytonus Therapeutics, Inc. is a biotech company headquartered in Carlsbad, United States. It has raised at least $14.4M across the 5 funding rounds on record. Its most recent funding round, Series A, raised $11.7M in October 2023.
As of 16 November 2026. Source: Xcout Intel.
At least $14.4M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $11.7M | 1 named | |
| SEC Form D filing | $15,000 | — | |
| SEC Form D filing | $2.5M | — | |
| SEC Form D filing | $100,000 | — | |
| SEC Form D filing | $70,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Cytonus Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Dyno Therapeutics is a biotechnology research company headquartered in Watertown, Massachusetts, specializing in gene therapy delivery solutions using artificial intelligence.
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Cytonus Therapeutics, Inc.? Suggest a correction · Work at Cytonus Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.